FDA approves abemaciclib for advanced breast cancerSeptember 28, 2017Breast CancerMetastatic Breast Cancer
HER2 status differed between primary tumor and CTCs in 18.8% of women with MBCSeptember 28, 2017Breast CancerMetastatic Breast Cancer
